1 The Development of Novel Compounds Against Malaria: Quinolines, Triazolpyridines, Pyrazolopyridines and Pyrazolopyrimidines.

2 Physicochemical Quality Assessment of Antimalarial Medicines: Chloroquine Phosphate and Quinine Sulfate Tablets from Drug Retail Outlets of South-West Ethiopia.

3 Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies.

4 Chloroquine and COVID-19 - a potential game changer?

5 Clinical Pharmacology Perspectives on the Antiviral Activity of Azithromycin and Use in COVID-19.

6 Brief Review on COVID-19: The 2020 Pandemic Caused by SARS-CoV-2.

7 COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus.

8 Anti COVID-19 Drugs: Need for More Clinical Evidence and Global Action.

9 [Hydroxychloroquine. Cardiology's viewpoint in times of coronavirus pandemic].

10 A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2.

11 Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.

12 Repositioning PARP inhibitors for SARS-CoV-2 infection (COVID-19); a new multi-pronged therapy for ARDS?

13 QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review.

14 Synthesis of Novel G Factor or Chloroquine-Artemisinin Hybrids and Conjugates with Potent Antiplasmodial Activity.

15 Synthesis and biological evaluation of novel quinoline-piperidine scaffolds as antiplasmodium agents.

16 Chloroquine commonly induces hormetic dose responses.

17 inhibition of m/kv7 currents contributes to chloroquine-induced itch in mice

18 influence of chloroquine on kinetics of single-cell gel electrophoresis

19 chloroquine sensitivity of plasmodium falciparum in berakit, bintan island, sumatra, after mass chemoprophylaxis through community participation, and its sociological studies

20 screening for chloroquine maculopathy in populations with uncertain reliability in outcomes of automatic visual field testing

21 revisitation of an old antimalarial to combat psoriatic arthritis administering an antidote to santonin to avoid xanthopsia or maculopathy

22 in-vitro antimalarial activity of azithromycin against chloroquine sensitive and chloroquine resistant plasmodium falciparum.

23 maculopatia tóxica por antimaláricos: detecção pela tomografia óptica espectral de alta resolução: relato de casos toxic maculopathy caused by antimalarial drugs: detection using spectral domain oct: case reports

24 effect of l1-orf2 on senescence of ges-1 cells and its molecular mechanisms

25 eficacia terapéutica de tres esquemas de tratamiento de malaria no complicada por plasmodium falciparum, antioquia, colombia, 2002.

26 infection of anopheles darlingi fed on patients infected with plasmodium vivax before and during treatment with chloroquine plus primaquine in costa marques, rondônia, brazil

27 pfcrt and pfmdr1 alleles associated with chloroquine resistance in plasmodium falciparum from guyana, south america

28 Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

29 Molecular analysis of markers associated with chloroquine and sulfadoxine/pyrimethamine resistance in Plasmodium falciparum malaria parasites from southeastern Côte-d'Ivoire by the time of Artemisinin-based Combination Therapy adoption in 2005

30 Hydroxychloroquine usage in US patients, their experiences of tolerability and adherence, and implications for treatment: survey results from 3127 patients with SLE conducted by the Lupus Foundation of America.

31 Liquid Silicone-Induced Extensive and Debilitating Granulomatosis Responding to Hydroxychloroquine.

32 Detection of histidine rich protein 2 and panmalarial ICT Malaria Pf/Pv test antigens after chloroquine treatment of uncomplicated falciparum malaria does not reliably predict treatment outcome in eastern Indonesia.

33 Stabilization of chloroquine resistance in vivo of plasmodium falciparum in edea, south cameroon

34 Increase of chloroquine resistance in vivo of plasmodium falciparum over two years in edea, South Cameroon

35 Of chloroquine and COVID-19

36 The Trial of Chloroquine in the Treatment of Corona Virus Disease 2019 （COVID-19） and Its Research Progress in Forensic Toxicology.

37 A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: Will cases of psoriasis increase after COVID-19 pandemic?

38 Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.

39 Meeting the Potential Emergency Global Drug Supply Challenge of Hydroxychloroquine for COVID-19.

40 Chloroquine for SARS-CoV-2: Implications of Its Unique Pharmacokinetic and Safety Properties.

41 Chloroquine Paradox May Cause More Damage Than Help Fight COVID-19.

42 Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base.

43 A case of facial atrophic sarcoidosis in an adolescent, successfully treated by the combination of prednisone and hydroxychloroquine.

44 Virological and Clinical Cure in Covid-19 Patients Treated with Hydroxychloroquine: A Systematic Review and Meta-Analysis.

45 SARS CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and Other Drugs for the Treatment of the New Coronavirus.

46 Hydroxychloroquine and covid-19.

47 Does hydroxychloroquine prevent the transmission of covid-19?

48 SLE, hydroxychloroquine and no SLE patients with covid-19: a comment.

49 : hydroxychloroquine, covid-19 and the role of the rheumatologist.

50 Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

51 Hydroxychloroquine Retinopathy in the Era of Advanced Imaging Modalities

52 Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries

53 Covid-19, dans les brouillards français de l’hydroxychloroquine

54 Generalized Pustular Figurate Erythema A Newly Delineated Severe Cutaneous Drug Reaction Linked with Hydroxychloroquine

55 Hydroxychloroquine Mitigates the Production of 8-Isoprostane and Improves Vascular Dysfunction: Implications for Treating Preeclampsia

56 Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial

57 Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence

58 Hydroxychloroquine-induced Retinal Toxicity

59 Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus

60 The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study

61 Additional Analyses to Confirm Relationship of Hydroxychloroquine Blood Levels to Retinopathy: Comment on the Article by Petri et al

62 Hydroxychloroquine suppresses lung tumorigenesis via inducing FoxO3a nuclear translocation through STAT3 inactivation

63 Evaluation of an Immediate-Release Formulation of Hydroxychloroquine Sulfate With an Interwoven Pediatric Taste-Masking System

64 Drug-induced Sweet's syndrome related to hydroxychloroquine: About 2 cases

65 Covid-19: six million doses of hydroxychloroquine donated to US despite lack of evidence

66 Hydroxychloroquine-induced auditory toxicity

67 Comment on: Adherence to hydroxychloroquine improves long-term survival of patients with systemic lupus erythematosus

68 Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology

69 An update on the use of hydroxychloroquine in cutaneous lupus erythematosus: A systematic review

70 Hydroxychloroquine-induced erythema multiforme

71 Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy

72 Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: A Nationwide, population-based case-control study

73 Rapamycin and hydroxychloroquine combination alters macrophage polarization and sensitizes glioblastoma to immune checkpoint inhibitors

74 Hydroxychloroquine-induced bull's eye maculopathy

75 Hydroxychloroquine Induced Retinopathy: A Case Series

76 Effect of Hydroxychloroquine on the Retinal Layers: A Quantitative Evaluation with Spectral-Domain Optical Coherence Tomography

77 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.

78 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.

79 Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated with Hydroxychloroquine and/or Azithromycin.

80 Combined treatment of tocilizumab and chloroquine on severe COVID-19: a case report.

81 Response to the editorial “COVID-19 in patients with cardiovascular diseases”: Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes

82 Rheumotologitsts' view on the use of hydroxychloroquine to treat COVID-19

83 Review on the clinical pharmacology of hydroxychloroquine sulfate for the treatment of COVID-19.

84 Azithromycin and ciprofloxacin have a chloroquine-like effect on respiratory epithelial cells.

85 The endosomal lipid bis(monoacylglycero) phosphate as a potential key player in the mechanism of action of chloroquine against SARS-COV-2 and other enveloped viruses hijacking the endocytic pathway.

86 Hydroxychloroquine as an aerosol might markedly reduce and even prevent severe clinical symptoms after SARS-CoV-2 infection.

87 Synthesis and biological characterization of clicked chloroquine copolymers as macromolecular inhibitors of cancer cell migration

88 Synthesis of stable isotope–labeled chloroquine and amodiaquine and their metabolites

89 Synthesis, biological evaluation, and molecular modeling studies of chiral chloroquine analogues as antimalarial agents

90 Chloroquine Urea Derivatives: Synthesis and Antitumor Activity in Vitro

91 Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies

92 Facile synthesis of vanillin-based novel bischalcones identifies one that induces apoptosis and displays synergy with Artemisinin in killing chloroquine resistant Plasmodium falciparum

93 Design, synthesis and characterization of biogenic chloroquine silver nanoparticles as potential anticancer agent against neuroblastoma cells

94 Synthesis and Evaluation of Chloroquine-Containing DMAEMA Copolymers as Efficient Anti-miRNA Delivery Vectors with Improved Endosomal Escape and Antimigratory Activity in Cancer Cells

95 Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain

96 Overcoming chloroquine resistance in malaria: Design, synthesis and structure-activity relationships of novel chemoreversal agents

97 Overcoming chloroquine resistance in malaria: Design, synthesis, and structure-activity relationships of novel hybrid compounds

98 Total synthesis of malagashanine: a chloroquine potentiating indole alkaloid with unusual stereochemistry

99 4-Aminoquinoline derivatives: Synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites

100 Pentamethylcyclopentadienyl-rhodium and iridium complexes containing (N^N and N^O) bound chloroquine analogue ligands: Synthesis, characterization and antimalarial properties

101 Palladium-catalyzed regioselective aerobic oxidative cyclization via C-H activation in chloroquine analogues: Synthesis and cytotoxic study

Keyword Connections

Journals

Research Groups

Bibliographies